HC Wainwright Reaffirms “Buy” Rating for BriaCell Therapeutics (NASDAQ:BCTX)
HC Wainwright restated their buy rating on shares of BriaCell Therapeutics (NASDAQ:BCTX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has a $18.00 price target on the stock. BriaCell Therapeutics Trading Up 0.7 % NASDAQ BCTX opened at $1.44 on Friday. The company has a […]
More Stories
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...